Alcon Rotational Leadership Program (RADAR)
Alcon
Summary
Accelerated RADAR (Rotational Assignments Developing Alcon Resources) is Alcon's highly selective, enterprise leadership development program designed to accelerate mid-career, high-performing leaders into senior leadership roles in Manufacturing and Quality. This program is structured to develop future senior leaders capable of leading complex, global, and regulated operations.
Job description
Program Structure
- Duration: ~4-5 years
- Rotations: 2 strategic enterprise rotations (~24 months each)
- Placement: Roles are strategically selected and aligned to enterprise priorities, with increasing scope, complexity, and accountability.
Program Intent
- Develop advanced enterprise leadership capability through strategically designed rotations across manufacturing operations, quality, and related functions
- Expose participants to global operations, emerging technologies, and regulated environments to strengthen systems thinking and adaptability
- Prepare top-performing talent for enterprise-wide impact by compounding technical depth and leadership scope across rotations
- Drive innovation, risk management, and business continuity through strategic projects and a capstone initiative delivering measurable outcomes
What Success Looks Like in Accelerated RADAR
- Rapidly assess, influence, and lead within complex, global, and highly regulated manufacturing and quality systems
- Demonstrate learning agility by entering unfamiliar technical, functional, or organizational domains and building credibility quickly
- Translate technical understanding (manufacturing, quality systems, automation, compliance, data) into business, risk, and performance outcomes
- Lead cross-functional teams through ambiguity, competing priorities, and enterprise trade-offs (quality, cost, delivery, risk)
- Build sustainable organizational capability through systems, governance, talent development, and continuous improvement
- Progressively assume enterprise-level accountability in preparation for Senior Leadership roles in Manufacturing & Quality
Rotation Assignment Examples (Depending on Experience)
First Rotation - Enterprise Foundation: Management roles within Automation, Manufacturing, Quality, Materials, Supply Chain, MS&T or Program Management. Focus on enterprise exposure, systems understanding, and cross-functional leadership.
Second Rotation - Enterprise Impact: Senior leadership roles within Manufacturing Operations, Quality Operations, Compliance, Materials Planning, MS&T, or Automation & Engineering. Focus on end-to-end accountability, strategic decision making, and business critical outcomes.
Each rotation increases responsibility in preparation for a transition to senior leadership roles in Manufacturing or Quality. This program is intended for individuals who explicitly aspire to senior leadership roles within operations and/or quality, and who are prepared to assume full-site or enterprise accountability over time.
Program Support
Includes Steering Committee, HR Program Managers, Executive Mentor, Local Mentors to build a valuable network of peers, managers, and leaders across the company.
Key Features of Program
- Pairing with a mentor
- Cohort experience
- Opportunities to interact with senior leaders
- End of assignment and cohort presentations
- Participation in leadership development training, coaching & assessments
Selection Process
- Nomination by senior leadership
- Behavioral and enterprise-focus interviews
- Scenario-based assessments emphasizing ambiguity, systems thinking, and technical trade-offs
- Strategic placement aligned to enterprise succession priorities
Internal Applicants: High performance records (4's/5's). Must be nominated by their Senior Leader. Please ensure you have aligned and have obtained the endorsement of your local HR Site Head, manager, General Manager and Quality Site Head prior to applying for the position.
Requirements
- Bachelor's Degree or equivalent years of directly related experience (or high school +10 yrs; Assoc.+6 yrs; M.S.+0 yrs)
- 5+ years of strong leadership experience and performance
- Proven ability to lead change, drive innovation, and shape Alcon's culture
- Demonstrated cycles of leadership success in a professional business environment
- Data, automation, and digital/AI technical competence
- Strong problem solving, organizational, communication and analytical skills
- Self-starter attitude, strategic thinking and ability to navigate through ambiguity
- Global mindset and technology savvy
- Fluently read, write, understand and communicate in English
- Must be a citizen of the country of your current Alcon location
- Full mobility during program inclusion (typically 4-5 years)
- Able to meet the requirements for relocation, travel and all other requirements for potential International Assignments during the program
Benefits
- Leadership development training
- Coaching
- Mentorship program
- Networking opportunities
Company overview
Alcon Inc. is the global leader in eye care, dedicated to helping people see brilliantly. Founded in 1945 as a small pharmacy in Fort Worth, Texas, the company has grown into the world's largest eye care device company with complementary businesses in Surgical and Vision Care. As a Swiss-American multinational corporation headquartered in Geneva, Switzerland with major operations in Fort Worth, Texas, Alcon operates in 60 countries and serves patients in over 140 countries. The company's Surgical segment focuses on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery, and glaucoma surgery, including implantables, consumables, and surgical equipment. The Vision Care segment comprises daily disposable, reusable, and color-enhancing contact lenses, along with a comprehensive portfolio of ocular health products for dry eye, contact lens care, and ocular allergies. With over 75 years of heritage, Alcon has a long history of industry firsts and makes substantial annual investments in research and development to meet evolving customer needs and advance patient care. The company became an independent publicly-traded entity in 2019 after spinning off from Novartis.